Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 12, 2000, Pages 4568-4574

  Bender, Bernhard U ^a,d   Gutsche, Markus ^a   Gläsker, Sven ^a   Müller, Barbara ^a   Kirste, Günter ^a   Eng, Charis ^b,c   Neumann, Hartmut P H ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHROMOSOME ARM; CHROMOSOME MAP; CLINICAL ARTICLE; CONTROLLED STUDY; GENE CONTROL; GENE FREQUENCY; GENE LOCUS; GENE MUTATION; GERM LINE; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; METHYLATION; NEUROFIBROMATOSIS; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SIPPLE SYNDROME; TUMOR SUPPRESSOR GENE; VON HIPPEL LINDAU DISEASE;

EID: 0034485464     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.12.4568     Document Type: Article

References (67)

1. Familial risk for neuroendocrine tumors
2. Von Recklirtghausen's disease and pheochromocytomas
3. Clustering of features of von Hippel-Lindau syndrome: Evidence for a complex genetic locus
4. Identification of the von Hippel-Lindau disease tumor suppressor gene
5. Improved detection of germline mutations in the von Hippel-Lindau tumor suppressor gene
6. Mutation and cancer: Statistical study of retinoblastoma
7. Molecular genetic investigations of the mechanisms of tumourigenesis in von Hippel-Lindau disease: Analysis of allele loss in VHL tumours
8. Loss of heterozygosity on the short arm of chromosome 3 in sporadic, von Hippel-Lindau disease-associated, and familial pheochromocytoma
9. Somatic inactivation of the VHL gene in von Hippel-Lindau disease tumors
10. Mutations of the VHL tumour suppressor gene in renal carcinoma
11. Somatic mutations of the von Hippel-Lindau disease tumor suppressor gene in non-familial clear cell renal carcinoma
12. Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma
13. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas
14. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastomas
15. Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas
16. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma
17. Cytogenetic abnormalities in tumors of patients with von Hippel-Lindau disease
18. Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas
19. Mutations in the RET protooncogene and the von Hippel-Lindau disease tumor suppressor gene in sporadic and syndromic pheochromocytoma
20. Consistent association of 1p loss of heterozygosity with pheochromocytomas from patients with multiple endocrine neoplasia type 2 syndromes
21. Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2
22. Loss of heterozygosity on the short arm of chromosomes 1 and 3 in sporadic pheochromocytoma and extra-adrenal paraganglioma
23. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis
24. Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases
25. Genetic alterations of the RET proto-oncogene in familial and sporadic pheochromocytomas
26. Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: Evidence for a founder effect
27. Genotype-phenotype correlations in von Hippel-Lindau disease
28. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease
29. Analysis of the VNTR locus D1S80 by the PCR followed by high-resolution PAGE
30. A device for processing large acrylamide gels
31. RET proto-oncogene point mutations in sporadic neuroendocrine tumors
32. Mapping the human amylase gene cluster on the proximal short arm of chromosome 1 using a highly informative (CA)n repeat
33. An Alu variable polyA repeat polymorphism upstream of L-myc at 1p32
34. Isolation and chromosomal assignment of 100 highly informative human simple sequence repeat polymorphisms
35. A PCR linkage map of human chromosome 1
36. Physical and genetic mapping of human chromosome 3 loci containing microsatellite repeats
37. A microsatellite-based multipoint index map of human chromosome 22
38. Dinucleotide repeat polymorphism at the D22S268 locus
39. A PCR generated AccI RFLP in the 3′untranslated region of the von Hippel-Lindau disease (VHL) tumour suppressor gene
40. Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and Japan
41. Mutation in the RET protooncogene in sporadic pheochromocytomas
42. Sporadic pheochromocytomas are rarely associated with germline mutations in the VHL tumor suppressor gene or the RET protooncogene
43. Prognostic value of RET proto-oncogene point mutations in malignant and benign, sporadic phaeochromocytomas
44. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
45. Human retinoblastoma susceptibility gene: Cloning, identification, and sequence
46. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma
47. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms
48. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression
49. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients
50. Molecular analysis of APC mutations in familial adenomatous polyposis and sporadic colon carcinomas
51. BRCA1 mutations in primary breast and ovarian carcinomas
52. BRCA2 mutations in primary breast and ovarian cancers
53. Absence of mutations in the ATM gene in forty-seven cases of sporadic breast cancer
54. Distinct molecular pathogeneses of early-onset breast cancers in BRCA1 and BRCA2 mutation carriers: A population-based study
55. Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer
56. APC mutations in sporadic colorectal tumors: A mutational "hotspot" and interdependence of the "two hits"
57. Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma
58. Loss of the putative tumor suppressor-gene locus 1p36 as investigated by a PCR-assay and N-myc amplification in 48 neuroblastomas: Results of the German Neuroblastoma Study Group
59. Two distinct deleted regions on the short arm of chromosome 1 in neuroblastoma
60. Chromosomal aberrations in human neuroblastomas
61. Karyotypic evolution in human malignant melanoma
62. Cytogenetic studies in primary and metastatic neuroendocrine Merkel cell carcinoma
63. Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression
64. p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent
65. Infrequent somatic mutations of the p73 gene in various human cancers
66. The von Hippel-Lindau tumour suppressor protein: New perspectives